Side effects may include heart problems if given too quickly by injection into a vein.[4] By mouth it can result in abdominal pain, peptic ulcer disease, or gastrointestinal bleeding.[4] Greater care is recommended in those with kidney problems.[2] As long as high blood potassium does not occur, use in pregnancy or breastfeeding is believed to be safe for the baby.[5] Generally, the strength of the formulation for injection into a vein should not be greater than 40 mmol/L (3 mg/L).[4]
Because of the risk of small-bowel lesions, the US Food and Drug Administration (FDA) requires some potassium salts containing more than 99 mg (about 1.3 mEq) to be labeled with a warning,[14] while recommending an adult daily intake of 4700 mg (about 63 mEq).
History
Slow-K is a 1950s development where the medicine is formulated to enter the bloodstream at delayed intervals. It was first only prescribed to British military forces to balance their diets while serving in Korea.[15]
Society and culture
Brand names
Brand names include K-Dur, Klor-Con, Micro-K, Slow-K, Sando-K, and Kaon Cl.
Lethal injection
Potassium chloride is used in lethal injection as the third of a three-drug combination. KCl is also sometimes used in fetal intracardiac injections in second- and third-trimester induced abortions.[16][17]Jack Kevorkian's thanatron machine injected a lethal dose of potassium chloride into the patient, which caused the heart to stop functioning, after a sodium thiopental-induced coma was achieved.[18]
Cardiac arrest induced by potassium has been used in political assassinations in Iran, by injection or by inserting a potassium suppository into the victim's rectum.[19]
^BNA's Patent, Trademark & Copyright Journal. Bureau of National Affairs, Incorporated. 1991. Archived from the original on 18 September 2017. Potassium chloride, used since the 1950s for the treatment of potassium depletion in humans
^World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.